Mogelijk gemaakt door 
Translate
Translate|
` |
27 February 2026 |
Gooch & Housego PLC
("G&H" or the "Company")
Gooch & Housego PLC (AIM: GHH), the specialist manufacturer of photonic components & systems, held its Annual General Meeting earlier today and confirms all resolutions put to the meeting, except resolution 2, were duly passed.
The Board notes that more than 50% of the votes cast on resolution 2, to receive and approve the Remuneration Committee Report, were against that resolution. The Company consulted with its largest institutional shareholders with regards to its remuneration proposals in advance of preparing the Remuneration Committee Report and their feedback as a whole was taken into account. Whilst Resolution 2 is an advisory vote, the Board takes shareholder views very seriously and will engage further with shareholders to solicit additional feedback from those who voted against the resolution to understand their reasoning. In accordance with the UK Corporate Governance Code, which the Company has chosen to adopt, the Company will publish the outcome of this engagement within six months.
The Board also notes that, for resolution 12, more than 20% of the votes cast were against that resolution. As part of the shareholder engagement described above, the Company will solicit further feedback on the resolution and publish the outcome within six months.
A breakdown of the proxy votes lodged prior to, and votes received at the meeting, for each resolution is set out below:
|
No. |
Resolution |
Total of Proxy Votes and Votes at the AGM |
||
|
FOR |
AGAINST |
WITHHELD* |
||
|
1. |
To receive the Annual Report and Financial Statements for the financial year ended 30 September 2025 together with the Directors' Report and Auditors' Report thereon |
17,244,077 |
65 |
3,085 |
|
2. |
To receive and approve the Remuneration Committee Report set out on pages 94 to 103 of the Annual Report and Financial Statements for the financial year ended 30 September 2025 |
7,949,928 |
9,289,392 |
7,907 |
|
3 |
To declare a final dividend, as recommended by the Directors, of 8.3 pence per ordinary share for the financial year ended 30 September 2025 |
15,975,112 |
1,271,866 |
249 |
|
4. |
To re-elect Gary Bullard as a Director |
13,925,455 |
11,565 |
3,310,207 |
|
5. |
To re-elect Charlie Peppiatt as a Director |
17,235,377 |
3,643 |
8,207 |
|
6. |
To re-elect Louise Evans as a Director |
13,928,087 |
8,933 |
3,310,207 |
|
7. |
To re-elect Jim Haynes as a Director |
13,927,675 |
9,345 |
3,310,207 |
|
8. |
To re-elect Susan Searle as a Director |
13,877,697 |
59,323 |
3,310,207 |
|
9. |
To re-appoint PricewaterhouseCoopers LLP as Auditors to the Company |
17,107,312 |
55,102 |
84,813 |
|
10. |
To authorise the Directors to fix the Remuneration of the Auditors of the Company |
17,240,365 |
3,697 |
3,165 |
|
11. |
To authorise the Directors' to allot shares pursuant to section 551 of the Companies Act 2006 |
13,940,902 |
3,305,700 |
625 |
|
12 |
Special resolution to authorise the Directors' to allot shares pursuant to section 570 of the Companies Act 2006 and to partially disapply statutory rights of pre-emption |
13,670,622 |
3,573,980 |
2,625 |
|
13 |
Special Resolution to authorise the Company to purchase its own shares pursuant to section 701 of the Companies Act 2006 |
13,584,898 |
5,281 |
3,657,048 |
* A "vote withheld" is not a vote in law and is not counted in the calculation of the percentages of votes cast for and against a resolution.
For further information please contact:
|
Charlie Peppiatt, Chief Executive Officer
|
Gooch & Housego PLC |
+44 (0) 1460 256440 |
|
|
|
|
|
Mark Court / Sophie Wills / Abigail Gilchrist |
Burson Buchanan |
+44 (0) 20 7466 5000 |
|
|
|
|
|
Christopher Baird / David Anderson |
Investec Bank plc |
+44 (0) 20 7597 5970 |
Notes to editors
1. Gooch & Housego is a photonics technology business headquartered in Ilminster, Somerset, UK with operations in the USA and Europe. A world leader in its field, the company researches, designs, engineers and manufactures advanced photonic systems, components and instrumentation for applications in the Aerospace & Defence, Industrial, Life Sciences and Scientific Research sectors. World leading design, development and manufacturing expertise is offered across a broad range of complementary technologies.
